The macrophage migration inhibitory factor (MIF) as a therapeutic and diagnostic target
538 بار بازدید -
2 سال پیش
-
Christine Landlinger-Schubert, PhD, OncoOne, Klosterneuburg,
Christine Landlinger-Schubert, PhD, OncoOne, Klosterneuburg, Austria, talks on the macrophage migration inhibitory factor (MIF) as a target for the treatment of both solid tumors and chronic inflammatory diseases, as well as a diagnostic tool. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.
2 سال پیش
در تاریخ 1401/05/19 منتشر شده
است.
538
بـار بازدید شده